NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.89
-0.36 (-2.09%)
At close: Apr 28, 2026, 4:00 PM EDT
17.22
+0.33 (1.95%)
After-hours: Apr 28, 2026, 4:56 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $573.42 million as of April 28, 2026. Its market cap has increased by 65.52% in one year.
Market Cap
573.42M
Enterprise Value
583.20M
1-Year Change
65.52%
Ranking
Category
Stock Price
$16.89
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $573.42M, an increase of 45.81%. That is a compound annual growth rate of 7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 585.65M | 13.88% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuidelOrtho | 789.07M |
| BrainsWay | 665.25M |
| SI-BONE | 597.11M |
| Tactile Systems Technology | 570.35M |
| Cytek Biosciences | 565.62M |
| Varex Imaging | 525.25M |
| Perspective Therapeutics | 514.22M |
| Beta Bionics | 497.75M |